WebNov 8, 2024 · Registration requirements for medical devices in Vietnam are currently in a state of transition. New rules governing the registration of medical devices were … WebApr 11, 2024 · 17.34 (+177.44%) Earnings Date. May 1, 2024. According to 9 analysts, the average rating for MYNZ stock is "Buy." The 12-month stock price forecast is $17.34, …
Did you know?
WebApr 10, 2024 · ColoAlert Revenue Increases 130% Year over Year. Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection … WebApr 10, 2024 · Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular ...
WebMar 29, 2024 · BERKELEY, US MAINZ, Germany March 29, 2024 Mainz Biomed NV (NASDAQ:MYNZ) (Mainz Biomed or the Company), a molecular genetics diagnostic company specializing in the early detection of cancer ... WebApr 10, 2024 · Mainz Biomed macht 2024 einen Umsatz von 0,53 Millionen Dollar, im Vorjahr waren es 0,58 Millionen Dollar. Die F&E-Ausgaben steigen von 0,47 Millionen …
Web21 hours ago · The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Mainz Biomed B.V. with a $18.00 average price target, which is a 208.85% upside from current levels. WebApr 13, 2024 · 4.5%. Market Average Movement. 5.0%. 10% most volatile stocks in DE Market. 9.7%. 10% least volatile stocks in DE Market. 2.7%. Stable Share Price: 4TO is …
WebApr 10, 2024 · Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) — Mainz Biomed N.V. MYNZ (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today financial results for the fiscal year ended …
WebApr 10, 2024 · Year End Cash Balance of $17.1 Million. BERKELEY, US - MAINZ, Germany - April 10, 2024 - Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the … grand yazici club marmaris palace turkeyWebApr 4, 2024 · Mainz Biomed NV, a molecular genetics diagnostic company specializing in the early detection of cancer, announced that three German-based companies have selected ColoAlert®, the Company’s highly efficacious and easy-to-use screening test for colorectal cancer into their respective corporate health programs. ... Filter News. All … grand ya lim seafoodWebApr 10, 2024 · Mainz Biomed B.V. GAAP EPS of -$1.86, revenue of $0.53M Apr. 10, 2024 7:09 AM ET Mainz Biomed N.V. (MYNZ) By: Deepa Sarvaiya , SA News Editor Mainz Biomed B.V. press release ( NASDAQ: MYNZ ): FY ... grand yazici club marmaris palace youtubeWebBIOMED synonyms, BIOMED pronunciation, BIOMED translation, English dictionary definition of BIOMED. n. A major regional or global biotic community, such as grassland … grand yazici hotels - club marmaris palaceWebFeb 16, 2024 · In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Mainz Biomed B.V. ( MYNZ – Research Report ), with a price target of $25.00. The company’s shares closed ... grandy barn door consoleWebMainz Biomed - Weichei007 schreibt: Beruhigt euch, man muss nicht auf alles Antworten 🙄 Und tut diesem SACHLICHEM Forum nicht gut. LG - Aktuellster Kommentar grand yazici club turban reviewsWebApr 4, 2024 · BERKELEY, US – MAINZ, Germany – [April 4, 2024] — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that three German-based companies, have selected ColoAlert®, the Company’s highly efficacious and easy … grand yazici club turban tripadvisor